Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 23:11:1309.
doi: 10.3389/fimmu.2020.01309. eCollection 2020.

Congenital Hemolytic Anemias: Is There a Role for the Immune System?

Affiliations
Review

Congenital Hemolytic Anemias: Is There a Role for the Immune System?

Anna Zaninoni et al. Front Immunol. .

Abstract

Congenital hemolytic anemias (CHAs) are a heterogeneous group of rare hereditary conditions including defects of erythrocyte membrane proteins, red cell enzymes, and disorders due to defective erythropoiesis. They are characterized by variable degree of anemia, chronic extravascular hemolysis, reduced erythrocyte life span, splenomegaly, jaundice, biliary lithiasis, and iron overload. Although few data are reported on the role of the immune system in CHAs, several immune-mediated mechanisms may be involved in the pathogenesis of these rare diseases. We reported in ~60% of patients with hereditary spherocytosis (HS), the presence of naturally-occurring autoantibodies (NAbs) directed against different membrane proteins (α- and β-spectrin, band 3, and dematin). Positive HS subjects showed a more hemolytic pattern and NAbs were more evident in aged erythrocytes. The latter is in line with the function of NAbs in the opsonization of damaged/senescent erythrocytes and their consequent removal in the spleen. Splenectomy, usually performed to reduce erythrocyte catheresis and improve Hb levels, has different efficacy in various CHAs. Median Hb increase is 3 g/dL in HS, 1.6-1.8 g/dL in pyruvate kinase deficiency (PKD), and 1 g/dL in congenital dyserythropoietic anemias (CDA) type II. Consistently with clinical severity, splenectomy is performed in 20% of HS, 45% of CDAII, and in 60% of PKD patients. Importantly, sepsis and thrombotic events have been registered, particularly in PKD with a frequency of ~7% for both. Furthermore, we analyzed the role of pro-inflammatory cytokines and found that interleukin 10 and interferon γ, and to a lesser extent interleukin 6, were increased in all CHAs compared with controls. Moreover, CDAII and enzymatic defects showed increased tumor necrosis factor-α and reduced interleukin 17. Finally, we reported that iron overload occurred in 31% of patients with membrane defects, in ~60% of CDAII cases, and in up to 82% of PKD patients (defined by MRI liver iron concentration >4 mg Fe/gdw). Hepcidin was slightly increased in CHAs compared with controls and positively correlated with ferritin and with the inflammatory cytokines interleukin 6 and interferon γ. Overall the results suggest the existence of a vicious circle between chronic hemolysis, inflammatory response, bone marrow dyserythropoiesis, and iron overload.

Keywords: congenital hemolytic anemias; cytokines; inflammation; iron overload; naturally occurring antibodies; splenectomy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The several roles of Naturally Occurring Antibodies (NAbs).
Figure 2
Figure 2
Cytokine and erythropoietin serum levels in congenital hemolytic anemias. Values are expressed as mean±SD. Data obtained from Barcellini et al. (94).
Figure 3
Figure 3
Vicious circle among chronic hemolysis, inflammatory response and iron overload. IL, Interleukin; IFN, Interferon; TfSat, Transferrin saturation; NTBI, Non-transferrin-bound serum iron.

References

    1. Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. (2008) 372:1411–26. 10.1016/S0140-6736(08)61588-3 - DOI - PubMed
    1. Narla J, Mohandas N. Red cell membrane disorders. Int J Lab Hematol. (2017) 39:47–52. 10.1111/ijlh.12657 - DOI - PubMed
    1. Iolascon A, Andolfo I, Russo R. Advances in understanding the pathogenesis of red cell membrane disorders. Br J Haematol. (2019) 187:13–24. 10.1111/bjh.16126 - DOI - PubMed
    1. Mohandas N, Gallagher PG. Red cell membrane: Past, present, and future. Blood. (2008) 112:3939–48. 10.1182/blood-2008-07-161166 - DOI - PMC - PubMed
    1. Niss O, Chonat S, Dagaonkar N, Almansoori MO, Kerr K, Rogers ZR, et al. . Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis. Blood Cells Mol Dis. (2016) 61:4–9. 10.1016/j.bcmd.2016.07.003 - DOI - PMC - PubMed

Publication types

LinkOut - more resources